Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Breast 4Other solid neoplasm 3Thoracic 2Genitourinary 2Tumor-Agnostic 1Other hematologic neoplasm 1Other 1NET 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Radiation Injuries 1Glioblastoma 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acupressure × CNS × Clear all
NCT03185780 2018-11-28

Complementary/Integrative Medicine for Brain Cancer Patients

The Chaim Sheba Medical Center

Phase NA Withdrawn
CNS

Glioblastoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡